A trial looking at cediranib with paclitaxel or olaparib for women with womb cancer (COPELIA)

Overview

Cancer types:

Secondary cancers, Womb (uterine or endometrial) cancer

Status:

Results

Phase:

Phase 2

Details

This trial compared treatments for women with womb cancer that had come back or spread to another part of the body. Womb cancer is also called uterine or endometrial cancer.

People could join this trial between 2018 and 2021. The team presented the results at conferences in 2024 and 2025. They hope to publish the results in a medical journal soon.

Recruitment start: 1 May 2018

Recruitment end: 31 December 2021

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Gordon Jayson

Dr Andrew Clamp

Supported by

University of Manchester

Cardiff University

AstraZeneca

Last reviewed: 08 Jun 2026

CRUK internal database number: 15103

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Find a Clinical Trial

Search our clinical trials database for all cancer trials and studies recruiting in the UK.

An icon of two speech bubbles, indicating a conversation.

Cancer Chat forum

Connect with other people affected by cancer and share your experiences.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.